Veradermics Inc., the New Haven drug developer working on an oral treatment for hair loss, said it expects to raise about $181.8 million in its planned initial public offering.
L’Oreal has filed a patent for a developer composition used in hair coloring. The composition includes direct dyes with halogenated aromatic groups, oxidizing agents, and water, with a pH range of 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results